Good Therapeutics, Inc.

About Good Therapeutics, Inc.

Good Therapeutics, Inc. is an early stage biotech company that is creating a new class of protein therapeutics that will be delivered systemically but activated locally, with an initial focus in immuno-oncology. Our core technology is an algorithm for designing allosterically-regulated proteins. These proteins change their conformation when they bind a marker, such as a cell surface marker or a metabolite. The binding event then activates a therapeutic domain. Our goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy.

We are located in Seattle, in the heart of Fremont.